IMB-1001
N/A
Report date: 2025/07/31 15:42:58
Base Information
Drug NameIMB-1001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTNAX Biopharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesTNAX Biopharma CorpIMIDomics IncFormation Biologics Corp +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A